Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
8348 | 1263 | 32.2 | 60% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
3 | 4 | PLANT SCIENCES//AGRONOMY//FOOD SCIENCE & TECHNOLOGY | 1882812 |
128 | 3 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY//CELLULASE//XYLANASE | 67277 |
2664 | 2 | L ASPARAGINASE//ASPARAGINASE//SOLID STATE FERMENTATION | 3431 |
8348 | 1 | L ASPARAGINASE//ASPARAGINASE//PEG ASPARAGINASE | 1263 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | L ASPARAGINASE | authKW | 5103772 | 23% | 71% | 296 |
2 | ASPARAGINASE | authKW | 2646333 | 13% | 64% | 170 |
3 | PEG ASPARAGINASE | authKW | 396688 | 2% | 86% | 19 |
4 | ERWINIA ASPARAGINASE | authKW | 290103 | 1% | 100% | 12 |
5 | ACUTE LYMPHOBLASTIC LEUKEMIA | authKW | 185102 | 13% | 5% | 160 |
6 | PEGASPARGASE | authKW | 175481 | 1% | 52% | 14 |
7 | ANTI ASPARAGINASE ANTIBODY | authKW | 145051 | 0% | 100% | 6 |
8 | ASPARAGINE SYNTHETASE | authKW | 113385 | 2% | 22% | 21 |
9 | ASPARAGINASE II | authKW | 108785 | 0% | 75% | 6 |
10 | ASPARAGINASE ACTIVITY | authKW | 96701 | 0% | 100% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 9750 | 27% | 0% | 342 |
2 | Oncology | 2841 | 26% | 0% | 325 |
3 | Pediatrics | 2520 | 16% | 0% | 203 |
4 | Biotechnology & Applied Microbiology | 846 | 12% | 0% | 154 |
5 | Biochemistry & Molecular Biology | 338 | 18% | 0% | 223 |
6 | Microbiology | 244 | 7% | 0% | 91 |
7 | Peripheral Vascular Diseases | 68 | 3% | 0% | 37 |
8 | Biochemical Research Methods | 62 | 3% | 0% | 42 |
9 | Pharmacology & Pharmacy | 56 | 7% | 0% | 84 |
10 | Biophysics | 45 | 3% | 0% | 42 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ALL BFM STUDY | 54393 | 0% | 75% | 3 |
2 | MICROBIOL SERV DEV PROD | 48350 | 0% | 100% | 2 |
3 | PEDIAT ONCOL BIOSTAT COMPUTAT BIOL | 32232 | 0% | 67% | 2 |
4 | AC CIATEJ AC UNIDAD SU TE | 24175 | 0% | 100% | 1 |
5 | ACT HEMATOL ONCOL | 24175 | 0% | 100% | 1 |
6 | AL HAWEEJA TECH | 24175 | 0% | 100% | 1 |
7 | ANDHRA PRADESH IIIT | 24175 | 0% | 100% | 1 |
8 | AREA SUPPORT MED BATTAL 111THTEXAS ARMY GUA | 24175 | 0% | 100% | 1 |
9 | BIOL SCI CELLULAR BIOL | 24175 | 0% | 100% | 1 |
10 | BIOQUIM TECHNOL FARMACEUT | 24175 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PEDIATRIC BLOOD & CANCER | 11272 | 4% | 1% | 46 |
2 | JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 8125 | 3% | 1% | 35 |
3 | KLINISCHE PADIATRIE | 3605 | 2% | 1% | 20 |
4 | PEDIATRIC HEMATOLOGY AND ONCOLOGY | 3022 | 1% | 1% | 16 |
5 | AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 1960 | 1% | 1% | 9 |
6 | MEDICAL AND PEDIATRIC ONCOLOGY | 1872 | 1% | 1% | 14 |
7 | LEUKEMIA & LYMPHOMA | 1505 | 2% | 0% | 22 |
8 | BRITISH JOURNAL OF HAEMATOLOGY | 1464 | 2% | 0% | 29 |
9 | CANCER TREATMENT REPORTS | 1308 | 1% | 1% | 11 |
10 | PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY | 1053 | 0% | 1% | 6 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | L ASPARAGINASE | 5103772 | 23% | 71% | 296 | Search L+ASPARAGINASE | Search L+ASPARAGINASE |
2 | ASPARAGINASE | 2646333 | 13% | 64% | 170 | Search ASPARAGINASE | Search ASPARAGINASE |
3 | PEG ASPARAGINASE | 396688 | 2% | 86% | 19 | Search PEG+ASPARAGINASE | Search PEG+ASPARAGINASE |
4 | ERWINIA ASPARAGINASE | 290103 | 1% | 100% | 12 | Search ERWINIA+ASPARAGINASE | Search ERWINIA+ASPARAGINASE |
5 | ACUTE LYMPHOBLASTIC LEUKEMIA | 185102 | 13% | 5% | 160 | Search ACUTE+LYMPHOBLASTIC+LEUKEMIA | Search ACUTE+LYMPHOBLASTIC+LEUKEMIA |
6 | PEGASPARGASE | 175481 | 1% | 52% | 14 | Search PEGASPARGASE | Search PEGASPARGASE |
7 | ANTI ASPARAGINASE ANTIBODY | 145051 | 0% | 100% | 6 | Search ANTI+ASPARAGINASE+ANTIBODY | Search ANTI+ASPARAGINASE+ANTIBODY |
8 | ASPARAGINE SYNTHETASE | 113385 | 2% | 22% | 21 | Search ASPARAGINE+SYNTHETASE | Search ASPARAGINE+SYNTHETASE |
9 | ASPARAGINASE II | 108785 | 0% | 75% | 6 | Search ASPARAGINASE+II | Search ASPARAGINASE+II |
10 | ASPARAGINASE ACTIVITY | 96701 | 0% | 100% | 4 | Search ASPARAGINASE+ACTIVITY | Search ASPARAGINASE+ACTIVITY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ALI, U , NAVEED, M , ULLAH, A , ALI, K , SHAH, SA , FAHAD, S , MUMTAZ, AS , (2016) L-ASPARAGINASE AS A CRITICAL COMPONENT TO COMBAT ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL): A NOVEL APPROACH TO TARGET ALL.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 771. ISSUE . P. 199 -210 | 77 | 88% | 6 |
2 | BATOOL, T , MAKKY, EA , JALAL, M , YUSOFF, MM , (2016) A COMPREHENSIVE REVIEW ON L-ASPARAGINASE AND ITS APPLICATIONS.APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY. VOL. 178. ISSUE 5. P. 900 -923 | 70 | 86% | 7 |
3 | DE STEFANO, V , ZA, T , CIMINELLO, A , BETTI, S , ROSSI, E , (2015) HAEMOSTATIC ALTERATIONS INDUCED BY TREATMENT WITH ASPARAGINASES AND CLINICAL CONSEQUENCES.THROMBOSIS AND HAEMOSTASIS. VOL. 113. ISSUE 2. P. 247 -261 | 97 | 92% | 1 |
4 | HIJIYA, N , VAN DER SLUIS, IM , (2016) ASPARAGINASE-ASSOCIATED TOXICITY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA.LEUKEMIA & LYMPHOMA. VOL. 57. ISSUE 4. P. 748 -757 | 77 | 80% | 3 |
5 | LOPES, AM , DE OLIVEIRA-NASCIMENTO, L , RIBEIRO, A , TAIRUM, CA , BREYER, CA , DE OLIVEIRA, MA , MONTEIRO, G , DE SOUZA-MOTTA, CM , MAGALHAES, PD , AVENDANO, JGF , ET AL (2017) THERAPEUTIC L-ASPARAGINASE: UPSTREAM, DOWNSTREAM AND BEYOND.CRITICAL REVIEWS IN BIOTECHNOLOGY. VOL. 37. ISSUE 1. P. 82 -99 | 93 | 75% | 0 |
6 | ZUO, SH , ZHANG, T , JIANG, B , MU, WM , (2015) RECENT RESEARCH PROGRESS ON MICROBIAL L-ASPARAGINASES.APPLIED MICROBIOLOGY AND BIOTECHNOLOGY. VOL. 99. ISSUE 3. P. 1069 -1079 | 62 | 83% | 14 |
7 | SHRIVASTAVA, A , KHAN, AA , KHURSHID, M , KALAM, MA , JAIN, SK , SINGHAL, PK , (2016) RECENT DEVELOPMENTS IN L-ASPARAGINASE DISCOVERY AND ITS POTENTIAL AS ANTICANCER AGENT.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 100. ISSUE . P. 1 -10 | 55 | 83% | 5 |
8 | VERMA, N , KUMAR, K , KAUR, G , ANAND, S , (2007) L-ASPARAGINASE: A PROMISING CHEMOTHERAPEUTIC AGENT.CRITICAL REVIEWS IN BIOTECHNOLOGY. VOL. 27. ISSUE 1. P. 45 -62 | 94 | 65% | 67 |
9 | FIGUEIREDO, L , COLE, PD , DRACHTMAN, RA , (2016) ASPARAGINASE ERWINIA CHRYSANTHEMI AS A COMPONENT OF A MULTI-AGENT CHEMOTHERAPEUTIC REGIMEN FOR THE TREATMENT OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA WHO HAVE DEVELOPED HYPERSENSITIVITY TO E. COLI-DERIVED ASPARAGINASE.EXPERT REVIEW OF HEMATOLOGY. VOL. 9. ISSUE 3. P. 227 -234 | 52 | 83% | 3 |
10 | STOCK, W , DOUER, D , DEANGELO, DJ , ARELLANO, M , ADVANI, A , DAMON, L , KOVACSOVICS, T , LITZOW, M , RYTTING, M , BORTHAKUR, G , ET AL (2011) PREVENTION AND MANAGEMENT OF ASPARAGINASE/PEGASPARAGINASE-ASSOCIATED TOXICITIES IN ADULTS AND OLDER ADOLESCENTS: RECOMMENDATIONS OF AN EXPERT PANEL.LEUKEMIA & LYMPHOMA. VOL. 52. ISSUE 12. P. 2237 -2253 | 67 | 77% | 36 |
Classes with closest relation at Level 1 |